Stock Events

Stock Events

SpectraCure AB (publ) 

€0
1
-€0-87.5% Tuesday 07:04

Statistics

Day High
0
Day Low
0
52W High
0.22
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
40,966.8
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

15MayExpected
Q3 2020
Q1 2024
-0.02
0.31
0.64
0.98
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.03MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2OK.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, indirectly competing in the broader field of innovative medical treatments for cancer.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc provides a variety of medical technologies, including cancer therapies, competing in the medical device sector like SpectraCure.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops medical devices that are used in various interventional medical specialties, competing with SpectraCure's therapeutic technologies.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. manufactures medical devices, including those for cancer treatments, competing with SpectraCure's medical device offerings.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology, indirectly competing with SpectraCure's cancer therapies.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical, Inc. focuses on musculoskeletal solutions but also explores treatments in adjacent medical fields, potentially overlapping with SpectraCure's market.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. engages in biopharmaceutical research including oncology, which could compete with SpectraCure's photodynamic therapy for cancer treatment.

About

SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden.
Show more...
CEO
Dr. Johannes Swartling Ph.D.
Employees
13
Country
DE
ISIN
SE0007158118
WKN
000A2PD08

Listings

ST
SE
SPEC.ST
F
DE
2OK.F

0 Comments

Share your thoughts

FAQ

What is SpectraCure AB (publ) stock price today?▼
The current price of 2OK.F is €0 EUR — it has decreased by -87.5% in the past 24 hours. Watch SpectraCure AB (publ) stock price performance more closely on the chart.
What is SpectraCure AB (publ) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SpectraCure AB (publ) stocks are traded under the ticker 2OK.F.
Is SpectraCure AB (publ) stock price growing?▼
2OK.F stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year SpectraCure AB (publ) has showed a -99.92% decrease.
What is SpectraCure AB (publ) market cap?▼
Today SpectraCure AB (publ) has the market capitalization of 40,966.8
What is SpectraCure AB (publ) revenue for the last year?▼
SpectraCure AB (publ) revenue for the last year amounts to 0 EUR.
What is SpectraCure AB (publ) net income for the last year?▼
2OK.F net income for the last year is -4.03M EUR.
How many employees does SpectraCure AB (publ) have?▼
As of April 02, 2026, the company has 13 employees.
In which sector is SpectraCure AB (publ) located?▼
SpectraCure AB (publ) operates in the Health Care sector.
When did SpectraCure AB (publ) complete a stock split?▼
SpectraCure AB (publ) has not had any recent stock splits.
Where is SpectraCure AB (publ) headquartered?▼
SpectraCure AB (publ) is headquartered in Lund, DE.